kenclare
5.8K posts
@kenclare
Nurse, advocate, . Living with Obesity Stroke and Bipolar.Past Chair ECPO. PPI/E Lead, Leeds Beckett University. Executive Director UKCPO
Tirzepatide and semaglutide are both highly effective for the management of obesity. How the two drugs compare in patients with obesity but without diabetes has been unknown. Research findings from the SURMOUNT-5 phase 3b trial are summarized in a short video. nej.md/3GqiRm0
Today in Conference Room 3 at 13.30 Patients: The Untapped Tool in your Toolbox #AddressingObesityTogether #ECO2025
Important Topic Session: Syndemic of Obesity and Mental Health at 11:30 Auditorium 1. The #ECO2025 session is led by @amy_ahern and @kenclare. Listen to the presentations and join in on the Q&A session. @EASOobesityECN @EASOPresident @ECPObesity
Great session from @ECPObesity ❤️. @kenclare & team are the embodiment of what it means to be mission-driven. Learned so much from @susieb16 on the impact of stigmatising language and images over the years (that is still thoughtlessly used in intervention content and delivery)
#ECO2025 begins Sunday, 11th May in Malaga, 🇪🇸. Join more than 3500 delegates from across Europe and globally at the premier #obesity congress and meet fellow researchers, scientists and medical professionals. @EASOobesityECN @EASOpresident @SociedadSeedo
Calling all researchers, clinicians and public health professionals! Abstract submissions for #UKCO2025 will close on the 6th May. This is a fantastic opportunity to share your research and contribute to the UK's leading obesity conference. Submit here: buff.ly/9sDdCEm
Apply for two prestigious awards when submitting your #UKCO2025 abstract here: bit.ly/3XjwtoD ⭐️ Best Practice Award – For research with real-world impact ⭐️ Ken Clare Award – For outstanding patient & public engagement
